$ cat jobs/us-hematology-thought-leader-engagement-lead-southeast-us-pfizer-682ebf71eff3.json
US Hematology Thought Leader Engagement Lead - Southeast US
Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future. What You Will Achieve The US Hematology Thought Leader Engagement Lead (TLEL), will play a critical role on the growing US Hematology team by developing and executing an overarching Thought Leader engagement plan for key national and regional thought leaders in the field of Hematology. Pfizer ’s Hematology portfolio spans multiple products in lymphoma, multiple myeloma and leukemia. This leader will create a first-class experience for external stakeholders in Hematology, coordinating relationships end-to-end (research to end-of-lifecycle) and working as part of a broader cross-functional Pfizer team. Focusing on National, Emerging, and certain Community Thought Leaders, this person will be responsible for establishing and maintaining relationships across a wide variety of key Hematology thought leaders. The TLEL will be engaging Hematology Thought Leaders via 1:1 engagements at major congresses and national / regional product theaters to identify mutual points of interest between the TL and Pfizer Oncology Commercial, gathering insights on Hematology Thought Leader beliefs and preferences to inform development and execution of HCP commercial strategies / tactics, nominating TL